[Postoperative vaginal brachytherapy in endometrial cancer].
Several randomized studies published in recent years have greatly changed the management of postoperative endometrial cancer, especially for lesions of intermediate prognosis. Vaginal brachytherapy is now standard treatment for these lesions at the expense of external beam radiation, which, despite an improvement in locoregional control, has no impact on overall survival. This review aims to take stock of new indications for vaginal brachytherapy detailing the trials that led to change standards or care.
Institut de cancérologie Gustave-Roussy, Villejuif Cedex, France. renaud.mazeron@igr.fr
Renaud
R
Mazeron
Wassim
W
Khodari
Jennifer
J
Gilmore
Jérôme
J
Champoudry
Isabelle
I
Dumas
Philippe
P
Morice
Catherine
C
Lhommé
Christine
C
Haie-Méder
D001918:Brachytherapy / Q000379:methods*; D019583:Dose Fractionation, Radiation; D016889:Endometrial Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D005260:Female; D006801:Humans; D009367:Neoplasm Staging / Q000379:methods; D011182:Postoperative Care; D011379:Prognosis; D018714:Radiotherapy, Adjuvant / Q000379:methods; D016032:Randomized Controlled Trials as Topic